-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation
-
Developing an international network for clinical research: the Gynecological Cancer Intergroup experience
Michael A Quinn
Research Update: Clinical Investigation